Once-daily COPD portfolioNew data from the Novartis chronic obstructive pulmonary disease (COPD) portfolio has been presented at the American Thoracic Society (ATS) International Conference May 17-22, 2013 in Philadelphia, PA, USA. In total, Novartis presented 34 ... Hospital Pharmacy Europe, 20 hours ago
New data reinforces strength of Novartis once-daily COPD portfolio in improving ..
- Saudi Fransi Capital, 1 day ago
|
See all (910) images for "novartis" | ||||
Study: Women with advanced breast cancer feel isolatedThe survey by Novartis Oncology involved 1,273 women from 12 countries worldwide A new global survey sponsored by Novartis Oncology of nearly 1,300 women in 12 countries finds that despite breast cancer being the most common cancer in women ... Express Healthcare Management, 1 day ago
Women with advanced breast cancer feel isolated: Study
Express Pharma, 1 day ago
|
The cost of drugs: beyond the Supreme Court orderThe Supreme Court decision denying Novartis a patent for the cancer drug imanitib has been hailed as a victory for the affordable medicines movement. But it won't make much difference if doctors continue to prescribe expensive branded drugs, ... InfoChange, 5 days ago
Intellectual Property Battles in Solid-State Chemistry
Pharmaceutical Technology, 5 days ago
Evergreening Withers in India
Corporate Counsel, 6 days ago
What future for branded drugs in India?
Manufacturing Chemist, 6 days ago
|
Novartis (NVS) has no intention of pursing a bid for Actavis, Inc. (ACT)Novartis AG ADS (NYSE: NVS) has no intention of pursing a bid for Actavis, Inc. (NYSE: ACT).Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's ... Street Insider, 6 days ago
Novartis says has no intention of buying Actavis
Reuters, 6 days ago
Novartis says no intention of pursuing Actavis, Bloomberg reports Theflyonthewall.com
Yahoo! Finance, 6 days ago
We have no intention of buying Actavis: Novartis
SBICAP Securities, 5 days ago
|
Novartis India standalone Mar '13 sales at Rs 212.85 croreNovartis India has reported a sales standalone turnover of Rs 212.85 crore and a net profit of Rs 24.41 crore for the quarter ended Mar '13 Money Control, 1 week ago
Novartis India net profit declines 25.83% in the March 2013 quarter
Business Standard, 1 week ago
Novartis India Q4 net profit dips 26% at Rs 24 cr
Business Standard, 1 week ago
Novartis Q4 profit slips 25.8% on lower margins
Myiris, 1 week ago
|
Scleroderma Experts from Johns Hopkins, Northwestern and Stanford to Explain Symptoms and Treatment OptionsA Free Webinar provided by the Scleroderma Research Foundation with support from Gilead Sciences, MedImmune and Novartis PR Newswire SAN FRANCISCO, May 16, 2013 SAN FRANCISCO, May 16, 2013 /PRNewswire-USNewswire/ -- The nonprofit Scleroderma ... Reuters, 6 days ago
|
Novartis India fixes book closure for dividend AGMThe Register of Members Share Transfer Books of Novartis India will remain closed from July 18, 2013 to July 25, 2013 (both days inclusive) for the purpose of Payment of Dividend Annual General Meeting (AGM) of the Company to be held on July 25, 2013. Money Control, 1 week ago
|
3 students to represent India at Novartis biotech camp in SwitzerlandNovartis India has announced the next edition of the Novartis Biotechnology Leadership Camp (BioCamp) taking place in Hyderabad from July 8-10, 2013. BioCamp is a seminar organised by Novartis that brings talented students from diverse faculties and different ... Business Line, 1 week ago
|
Novartis AG appoints Citigroup as sole broker for share sale in Indian entityNovartis India , one of the leading pharma companies, today announced that its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share sale to reduce stake in the Indian entity. Earlier, in March Novartis India ... Myiris, 1 week ago
Novartis appoints Citigroup as broker for Indian co share sale
Business Standard, 1 week ago
Novartis hires Citigroup as broker for Indian unit shr sale
Money Control, 1 week ago
Novartis to cut promoters stake in India arm
Money Today, 1 month ago
|
Novartis, BT push European shares to fresh 5-yr peakLONDON, May 10 (Reuters) - European shares scaled freshfive-year highs on Friday, led by healthcare group Novartis and telecoms firm BT on positive corporatenews, and traders said key indexes Sify, 1 week ago
Swiss stocks lift European shares to fresh heights
Times of Malta, 5 days ago
No money, no Swiss
Tikkun Magazine, 6 days ago
*Fall in Swiss franc buoys Swiss stock market
Saudi Press Agency, 6 days ago
|